Search Results

Phorbol 12-Myristate 13-Acetate 10mg  | ≥99%

CSNpharm

Phorbol 12-myristate 13-acetate is a PKC-activating phorbol ester, increases the intracellular Ca2+ concentration ([Ca2+]i) in a dose-dependent manner, with an EC50 of 11.7 nM.

More Information Supplier Page

Teriflunomide(Random Configuration) 25mg  | ≥99%

CSNpharm

Teriflunomide, the active metabolite of an approved antirheumatic drug leflunomide, is an emerging oral therapy for multiple sclerosis (MS). It reversibly inhibits dihydroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines.

More Information Supplier Page

Teriflunomide(Random Configuration) 5g  | ≥99%

CSNpharm

Teriflunomide, the active metabolite of an approved antirheumatic drug leflunomide, is an emerging oral therapy for multiple sclerosis (MS). It reversibly inhibits dihydroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines.

More Information Supplier Page

Teriflunomide(Random Configuration) 100mg  | ≥99%

CSNpharm

Teriflunomide, the active metabolite of an approved antirheumatic drug leflunomide, is an emerging oral therapy for multiple sclerosis (MS). It reversibly inhibits dihydroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines.

More Information Supplier Page

Teriflunomide(Random Configuration) 1g  | ≥99%

CSNpharm

Teriflunomide, the active metabolite of an approved antirheumatic drug leflunomide, is an emerging oral therapy for multiple sclerosis (MS). It reversibly inhibits dihydroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines.

More Information Supplier Page

Teriflunomide(Random Configuration) 250mg  | ≥99%

CSNpharm

Teriflunomide, the active metabolite of an approved antirheumatic drug leflunomide, is an emerging oral therapy for multiple sclerosis (MS). It reversibly inhibits dihydroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines.

More Information Supplier Page

Nicaraven 10mg  | ≥99%

CSNpharm

Nicaraven is antioxidant agent exhibiting hydroxyl radical scavenging activity, with anti-inflammatory, neuroprotective and anti-ischemic effects as well as a high permeability through the blood brain barrier.

More Information Supplier Page

Nicaraven 50mg  | ≥99%

CSNpharm

Nicaraven is antioxidant agent exhibiting hydroxyl radical scavenging activity, with anti-inflammatory, neuroprotective and anti-ischemic effects as well as a high permeability through the blood brain barrier.

More Information Supplier Page

Nicaraven 100mg  | ≥99%

CSNpharm

Nicaraven is antioxidant agent exhibiting hydroxyl radical scavenging activity, with anti-inflammatory, neuroprotective and anti-ischemic effects as well as a high permeability through the blood brain barrier.

More Information Supplier Page